Highlights

• Alterity Therapeutics shares rose 14.61% to AUD 0.51 on 12 June 2026.
  • The stock traded between AUD 0.45 and AUD 0.52 during the session.
  • Alterity Therapeutics had a market capitalisation of approximately AUD 109.8 million.
  • The company remains focused on therapies targeting neurodegenerative diseases.
  • Clinical development milestones continue to be a major focus for investors.

Alterity Therapeutics Ltd (ASX: ATH) attracted market attention on 12 June 2026 after its shares climbed 14.61% to AUD 0.51. The stock opened at AUD 0.46 and traded within a range of AUD 0.45 to AUD 0.52 during the session, reflecting increased investor activity throughout the trading day.

The…